Catherine E. Owen
Director, OptiNose, Inc.
Companies
- Acadia PharmaceuticalsBoard member Sep 25, 2024 to now1
- Acadia PharmaceuticalsChief executive officer Sep 25, 2024 to now1
- Agios PharmaceuticalsBoard member Jun 15, 2023 to now2
- OptiNose, Inc.Board member Jul 30, 2020 to now3
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Agios Pharmaceuticals AGIO10,865 shares4$340.3K at $31.32Jun 18, 2026- Acadia Pharmaceuticals ACAD14,803 shares5$283.0K at $19.12Mar 25, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 18, 2026Exercised options 2,816 shares of Agios Pharmaceuticals4
- Jun 13, 2026Exercised options 1,976 shares of Agios Pharmaceuticals6
- Mar 25, 2026Sold 11,641 shares at $21.47 of Acadia Pharmaceuticals5
- Mar 24, 2026Exercised options 23,509 shares of Acadia Pharmaceuticals5
- Jun 20, 2025Exercised options 2,120 shares of Agios Pharmaceuticals7
- Jun 13, 2025Exercised options 1,977 shares of Agios Pharmaceuticals8
- Jun 13, 2024Exercised options 1,976 shares of Agios Pharmaceuticals9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAcadia Pharmaceuticals, Board member
- 2SEC EDGARAgios Pharmaceuticals, Board member
- 3SEC EDGAROptiNose, Inc., Board member
- 4
- 5
- 6SEC EDGARForm 4 filed Jun 16, 2026
- 7SEC EDGARForm 4 filed Jun 23, 2025
- 8SEC EDGARForm 4 filed Jun 17, 2025
- 9SEC EDGARForm 4 filed Jun 17, 2024